Denali Therapeutics (DNLI) Assets (2017 - 2026)
Denali Therapeutics' Assets was $1.16 billion in Q2 2026, down 0.7% from $1.17 billion a year earlier and down 8.5% from the prior quarter.
Powered by 
Analysis
Denali Therapeutics (DNLI) Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Assets at Denali Therapeutics came in at $1.14 billion, down 16.7% from FY2024.
- Assets shows a five-year compound annual growth rate of -6.5% (FY2020 to FY2025).
- In earlier years, Assets was $1.37 billion in FY2024 (+19.1%), $1.15 billion in FY2023 (-21.0%), $1.46 billion in FY2022 (+4.0%) and $1.4 billion in FY2021 (-12.5%).
- Quarterly Assets has moved between $1.06 billion (Q3 2025) and $1.58 billion (Q1 2024) over five years.
- Compared with a year earlier, Assets has declined for six straight quarters, with an average decline of 6.3% over the last eight quarters.
- The best year-over-year quarter for Assets over five years was Q3 2021 (growth of 35.5%); the worst was Q3 2025 (a decline of 27.4%).
- Per Business Quant data, DNLI's Assets in the three quarters before Q2 2026 was $1.27 billion (Q1 2026), $1.14 billion (Q4 2025) and $1.06 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.50 Bn | 1,103.09 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 616.20 Bn | 534.73 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 500.82 Bn | 473.93 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 367.31 Bn | 321.69 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 297.77 Bn | 261.76 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.35 Bn | 235.04 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 235.40 Bn | 190.80 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 190.59 Bn | 164.79 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 169.39 Bn | 116.04 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Denali Therapeutics | 3.51 Bn | 99.78 Mn | 3.51 Mn | 1.16 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.16 Bn |
| Mar 31, 2026 | 1.27 Bn |
| Dec 31, 2025 | 1.14 Bn |
| Sep 30, 2025 | 1.06 Bn |
| Jun 30, 2025 | 1.17 Bn |
| Mar 31, 2025 | 1.27 Bn |
| Dec 31, 2024 | 1.37 Bn |
| Sep 30, 2024 | 1.45 Bn |
| Jun 30, 2024 | 1.50 Bn |
| Mar 31, 2024 | 1.58 Bn |
| Dec 31, 2023 | 1.15 Bn |
| Sep 30, 2023 | 1.24 Bn |
| Jun 30, 2023 | 1.31 Bn |
| Mar 31, 2023 | 1.41 Bn |
| Dec 31, 2022 | 1.46 Bn |
| Sep 30, 2022 | 1.23 Bn |
| Jun 30, 2022 | 1.29 Bn |
| Mar 31, 2022 | 1.32 Bn |
| Dec 31, 2021 | 1.40 Bn |
| Sep 30, 2021 | 1.45 Bn |
API Access
Denali Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=DNLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "DNLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=DNLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();